Patent directory · USPTO A61K / A61P
Patents matching “Corvus Pharmaceuticals, Inc.”
14 pharma patents match "Corvus Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 14 pharmaceutical patents matching "Corvus Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12351644
Anti-CD73 antibodies
granted -
US 12174192
Methods for detecting and treating cancers having adenosine pathway activation
granted -
US 12116635
Methods for detecting and treating cancers having adenosine pathway activation
granted -
US 12023337
Methods of treating cancer
granted -
US 11897874
Compounds and methods for modulating Interleukin-2-inducible T-cell kinase
granted -
US 11859007
Humanized anti-CD73 antibodies
granted -
US 11266649
Pharmaceutical formulations
granted -
US 11254686
Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor
granted -
US 11040040
Methods of treating cancer
granted -
US 11008314
Compounds and methods for modulating interleukin-2-inducible t-cell kinase
granted -
US 10912776
Methods of treating cancer
granted -
US 10870652
Compounds and methods for modulating bruton's tyrosine kinase
granted -
US 10822426
Humanized anti-CD73 antibodies
granted -
US 10793636
Anti-CD73 antibodies
granted